Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the opening of a new branch in Baroda, India. This will house Operations (mainly Regulatory) and Support (mainly Finance) staff focused in particular upon Atnahs’ New Product Development (NPD) activities.
Amit Patel, Atnahs’ Managing Director, comments,
“NPD is a core pillar of Atnahs’ strategy. We see the opening of this branch as the first step in the creation of a Centre of Excellence for NPD in India.”
Atnahs is a family-owned specialty pharmaceutical business, focussed upon acquiring mature branded medicines globally, developing line extensions to them, and developing its own niche generic medicines. Atnahs has now completed eight major acquisitions since its inception in 2013, and now operates a portfolio of over 15 key medicines across more than 130 markets.